• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA draft guidance on 510(k)s omits combination devices

August 10, 2016 By Fink Densford

FDA logoCombination medical devices which bring together device components and drugs or biological products into a single unit are missing from new draft guidance from the FDA.

The guidance, released last week, covered recommendations for manufacturers on when to submit 510(k) applications for modifications to devices currently on the market, replacing guidance that was 19 years old.

The new information, however, didn’t touch on combination products, which are becoming more and more common within the industry.

Included in the draft guidance are updated guiding principles including recommendations for risk-based assessments to determine safety and effectiveness associated with modifications, updated flow charts and sections covering when to submit new 510(k)s for labeling, materials, tech, engineering and performance changes and examples of specific device changes that would require new 510(k) submissions.

The FDA included a separate set of guidance to address changes that are specific to health care software.

“These draft recommendations are intended to help manufacturers determine when a change is significant enough to warrant FDA review, including major changes or modifications to the intended use that could significantly impact safety and effectiveness. Medical device technology evolves quickly, and not all changes made to marketed devices alter their safety profile or require our review,” FDA Center for Devices and Radiological Health director Dr. Jeffrey Shuren said in prepared remarks.

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Regulatory/Compliance

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS